2 February 2023 - Restrained increases come as US implements the Inflation Reduction Act.
Pharmaceutical companies raised list prices of 983 arthritis, cancer and other prescription drugs by an average of 5.6% at the start of this year—restrained increases as the industry faces a new federal law aimed at lowering medicine costs.